U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07612254) titled 'aPBI Re-irradiation' on May 05.
Brief Summary: This study is to determine whether acute treatment-associated adverse events following breast re-irradiation with aPBI are acceptably low and to assess local control following breast re-irradiation with aPBI. An exploratory aim is to assess cosmetic outcomes following breast re-irradiation with aPBI.
Study Start Date: June 03
Study Type: INTERVENTIONAL
Condition:
Breast Cancer Recurrent
Intervention:
RADIATION: Reirradiation
aPBI, which is routinely used to treat patients who have previously not been irradiated, with a dose of 30 Gy in 5 fractions using a VMAT technique.
Recruitm...